Table 3 Eight significant SNP sites identified from the VeraCode ADME Core Panel.

From: Identification of two novel genes SLC15A2 and SLCO1B3 associated with maintenance dose variability of warfarin in a Chinese population

CHR

SNP

POSITION

A1

F_A

F_U

A2

CHISQ

P

OR

16

rs9923231

31107689

G

0.325

0.04545

A

11.16

0.0008347

10.11

11

rs2306168

74907582

T

0.425

0.1591

C

7.259

0.007053

3.907

3

rs2257212

121643804

C

0.475

0.2391

T

5.24

0.02207

2.879

3

rs1143671

121647286

C

0.475

0.2391

T

5.24

0.02207

2.879

3

rs1143672

121648168

G

0.475

0.2391

A

5.24

0.02207

2.879

12

rs4149056

21331549

C

0.175

0.04348

T

3.95

0.04688

4.667

12

rs4149117

21011480

T

0.275

0.1087

G

3.908

0.04807

3.11

12

rs7311358

21015760

G

0.275

0.1087

A

3.908

0.04807

3.11

  1. Note: CHR: Chromosome; SNP: SNP ID; BP: Physical position (base-pair); A1: Minor allele name (based on whole sample); F_A: Frequency of this allele in high dose group; F_U: Frequency of this allele in low dose group; A2: Major allele name; CHISQ: Basic allelic chi-square test (1df); P: Asymptotic p-value for this test; OR: Estimated odds ratio (for A1, i.e., A2 is the reference).